Hemogenyx Pharmaceuticals plc is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune disease and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.

Pharmaceutical

Hemogenyx Pharmaceuticals

Hemogenyx Pharmaceuticals' headquarters in London, United Kingdom

Vladislav Sandler

Elina Shrestha

Koen Van Besien

H. Michael Shepard

Peter Redmond

Marc Feldmann

Alexis M. Sandler

The Scientific Team at Hemogenyx Pharmaceuticals conducts pioneering research and development to advance new therapeutics for blood and autoimmune diseases. This team collaborates on pre-clinical experiments, analyzes data, and optimizes treatment protocols to bring innovative bone marrow transplantation solutions closer to clinical application, ultimately aiming to transform patient outcomes in otherwise incurable conditions.

Scientific Team

The Leadership Team at Hemogenyx Pharmaceuticals is responsible for strategic decision-making and guiding the direction of the company as it develops innovative therapies for blood and autoimmune diseases. Comprising influential figures with expertise in science, business, and management, the team oversees research initiatives, fosters partnerships, and ensures alignment with the company’s mission to make life-saving treatments more accessible.

Hemogenyx Pharmaceuticals

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Hemogenyx Pharmaceuticals

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies